These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3299681)

  • 41. Improved health-related quality of life for rheumatoid arthritis patients treated with abatacept who have inadequate response to anti-TNF therapy in a double-blind, placebo-controlled, multicentre randomized clinical trial.
    Westhovens R; Cole JC; Li T; Martin M; Maclean R; Lin P; Blaisdell B; Wallenstein GV; Aranda R; Sherrer Y
    Rheumatology (Oxford); 2006 Oct; 45(10):1238-46. PubMed ID: 16567357
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Health-related quality of life in women with symptomatic hand osteoarthritis: a comparison with rheumatoid arthritis patients, healthy controls, and normative data.
    Slatkowsky-Christensen B; Mowinckel P; Loge JH; Kvien TK
    Arthritis Rheum; 2007 Dec; 57(8):1404-9. PubMed ID: 18050180
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. Minocycline in Rheumatoid Arthritis Trial Group.
    Tuttleman M; Pillemer SR; Tilley BC; Fowler SE; Buckley LM; Alarcón GS; Trentham DE; Neuner R; Clegg DO; Leisen JC; Heyse SP
    J Rheumatol; 1997 Oct; 24(10):1910-5. PubMed ID: 9330931
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Long-term therapy with gold salts in rheumatoid arthritis. Review of the literature and personal contribution].
    Copertari N; Cordioli E; Martinelli M
    Minerva Med; 1993 May; 84(5):219-25. PubMed ID: 8316339
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparative evaluation of the effectiveness of gold preparations and D-penicillamine and their tolerance in rheumatoid arthritis. I. The effect on the indicators of their activity and tolerance].
    Slobodina GA; Kanevskaia MZ; Krel' AA; Chichasova NV
    Revmatologiia (Mosk); 1989; (1):8-16. PubMed ID: 2501852
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cyclosporin A in rheumatoid arthritis: overview of efficacy.
    Wells G; Tugwell P
    Br J Rheumatol; 1993 Mar; 32 Suppl 1():51-6. PubMed ID: 8448639
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Health-related quality of life outcomes of adalimumab for patients with early rheumatoid arthritis: results from a randomized multicenter study.
    Strand V; Rentz AM; Cifaldi MA; Chen N; Roy S; Revicki D
    J Rheumatol; 2012 Jan; 39(1):63-72. PubMed ID: 22045836
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incorporating utility-based quality-of-life assessment measures in clinical trials. Two examples.
    Feeny DH; Torrance GW
    Med Care; 1989 Mar; 27(3 Suppl):S190-204. PubMed ID: 2522159
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Longterm results of auranofin therapy.
    Bandilla KK; Missler B
    Clin Rheumatol; 1987 Sep; 6 Suppl 2():35-42. PubMed ID: 3690986
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Measuring costs and financial benefits in randomized controlled trials.
    Bulpitt CJ; Fletcher AE
    Am Heart J; 1990 Mar; 119(3 Pt 2):766-70; discussion 770-1. PubMed ID: 2106770
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Auranofin: Past to Present, and repurposing.
    Yamashita M
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108272. PubMed ID: 34731781
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methods of assessing the effect of drug therapy on quality of life.
    Ganz PA
    Drug Saf; 1990; 5(4):233-42. PubMed ID: 2198049
    [No Abstract]   [Full Text] [Related]  

  • 53. Long-term follow-up of technetium articular index in rheumatoid arthritis patients during oral chrysotherapy: evidence of paradoxical behaviour.
    Mathieu A; Pala R; Satta L; Piga M
    Clin Exp Rheumatol; 1988; 6(1):75-8. PubMed ID: 3396250
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methodologic challenges in the development of utility measures of health-related quality of life in rheumatoid arthritis.
    Bennett K; Torrance G; Tugwell P
    Control Clin Trials; 1991 Aug; 12(4 Suppl):118S-128S. PubMed ID: 1663849
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Quality of Well-being Scale. Applications in AIDS, cystic fibrosis, and arthritis.
    Kaplan RM; Anderson JP; Wu AW; Mathews WC; Kozin F; Orenstein D
    Med Care; 1989 Mar; 27(3 Suppl):S27-43. PubMed ID: 2921885
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Auranofin in rheumatoid arthritis: what variables could affect the clinical response?
    Harth M
    Agents Actions Suppl; 1988; 24():167-77. PubMed ID: 3055876
    [No Abstract]   [Full Text] [Related]  

  • 57. Auranofin: a new drug for rheumatoid arthritis.
    Ann Intern Med; 1987 Apr; 106(4):631-2. PubMed ID: 3826966
    [No Abstract]   [Full Text] [Related]  

  • 58. Outcome assessment in clinical trials. Evidence for the sensitivity of a health status measure.
    Meenan RF; Anderson JJ; Kazis LE; Egger MJ; Altz-Smith M; Samuelson CO; Willkens RF; Solsky MA; Hayes SP; Blocka KL
    Arthritis Rheum; 1984 Dec; 27(12):1344-52. PubMed ID: 6391495
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quality of life in patients receiving auranofin therapy: confirmation of efficacy using nontraditional health status measures.
    Morgan GJ
    Scand J Rheumatol Suppl; 1986; 63():29-35. PubMed ID: 3299681
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial.
    Bombardier C; Ware J; Russell IJ; Larson M; Chalmers A; Read JL
    Am J Med; 1986 Oct; 81(4):565-78. PubMed ID: 3532786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.